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West Nile virus (WNV) was isolated from the brains of
3 horses that died from encephalitis in February 2006. The
horses were from different farms in central Argentina and
had not traveled outside the country. This is the first isola-
tion of WNV in South America.
S
ince West Nile virus (WNV) was detected in the
Western Hemisphere in 1999 (1), the National Service
of Animal Health (SENASA) has restricted the entry of
WNV-susceptible species into the country, and the
National Reference Center for Dengue and Arboviral
Diagnosis of Argentina, Instituto Nacional de
Enfermedades Virales Humanas (INEVH “Dr. Julio I.
Maiztegui”) incorporated new laboratory techniques, per-
formed multidisciplinary training, and implemented labo-
ratory WNV surveillance for birds, equines, and humans.
The Study
In late February 2006, two horses died after encephali-
tis developed at 2 stud farms near San Antonio de Areco,
110 km north of the city of Buenos Aires (Figure 1).
Clinical signs included circling and acute onset ataxia,
hypersensitivity to noise, hyperexcitability, and recumben-
cy. Both mares (Eq001 and Eq002) died within 48 to 72
hours of onset of signs. Although each farm contained
≈300 horses, no other horses had clinical signs.
In March, another horse death was reported at the
Jockey Club horse training center in San Isidro, province
of Buenos Aires, within 48 hours after its arrival from a
polo horse farm near Victoria (Entre Rios Province)
(Figure 1). Clinical symptoms of the polo mare (Eq003)
were weakness, paralysis, and recumbency.
Brain tissues from the 3 horses were extracted for viro-
logic studies. Diagnostic tests for rabies virus (Dirección
de Laboratorios y Control Técnico, SENASA) and for
equine herpesvirus 1 (INTA Laboratory, Castelar,
Argentina) were performed, with negative results. At
INEVH, virus was isolated in African green monkey
(Vero) cells, as described (2). Briefly, 20% homogenates of
brain tissues were prepared and cultured in Vero cells for
14 days. Cultures were examined daily for evidence of
viral cytopathic effect (CPE). Infected cells that showed
CPEs were harvested and evaluated by immunofluorescent
assay (IFA) (3) for flavivirus antigen, by using fluorescein
isothiocyanate–labeled flavivirus polyclonal antisera
(Centers for Disease Control and Prevention, Puerto Rico),
and for WNV antigen by using the WNV-specific mono-
clonal immunoglobulin M (IgM)  antibody H5-46 and IgG
neutralizing monoclonal antibody 7H2. Cultures that did
not show CPEs on the original isolation were blind pas-
saged 1 more time onto fresh Vero monolayers. Three viral
isolates were obtained. Two cultures (ArEq001 and
ArEq003) showed CPEs on day 7 postinoculation of the
original isolation; in the third culture (ArEq002), CPEs
were observed only after the blind passage on day 7 after
inoculation. WNV antigen was demonstrated when the 3
culture isolates were examined by IFA. Negative results
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Figure 1. Locations of dead horses reported from February to
March 2006 in central Argentina.were obtained for Saint Louis encephalitis virus by using
the monoclonal antibody 6B5A-2. Negative results were
also obtained for the alphaviruses Western equine
encephalitis, Eastern equine encephalitis, and Venezuelan
equine encephalitis by using mouse hyperimmune ascitic
fluid. Titration of the supernatants by plaque assay gave
titers of 105 to 106 PFU/µL.
For molecular identification of the virus isolates, viral
RNA was extracted from 140 µL of infected Vero cell cul-
ture supernatant by using QIAamp viral RNA extraction
kit (Qiagen, Inc., Valencia, CA, USA). Nested reverse
transcription (nRT)–PCR assay was performed as
described by Shi et al. (4). A DNA band of the correct size
was visualized by gel electrophoreses of the RT-PCR prod-
uct. Using the nRT-PCR previously described by Johnson
et al. (5), the INTA laboratory also detected WNV RNA
directly from brain tissue from the 3 necropsy specimens.
In this case, total RNAwas extracted from 50 to 100 mg of
tissue by using Trizol reagent (Invitrogen Life
Technologies, Carlsbad, CA, USA). WNV NY99 RNA
lysate was employed as positive control. INEVH and
INTA laboratories did not have infectious WNV in their
virus collections.
DNAfragments from C/preM and NS5 genes amplified
by RT-PCR assays employing primers WN212/WN619c
(5′-TTGTGTTGGCTCTCTTGGCGTTCTT-3′/5′-CAGC-
CGACAGCACTGGACATTCATA-3′) and WN9483/
WN9794c (5′-CACCTACGCCCTAAACACTTTCACC-
3′/5′-GGAACCTGCTGCCAATCATACCATC-3′) were
sequenced. DNA products were analyzed on a 2% agarose
gel, and the bands of the correct predicted size were
excised and purified with the Gene Clean Kit (BIO 101,
Carlsbad, CA, USA). The nucleotide sequences were
determined by automatic dideoxy cycle sequencing tech-
niques (Applied Biosystems, Foster City, CA, USA).
Alignments were performed with BioEdit program by the
Clustal Wallis method (available from http://www.mbio.
ncsu.edu/BioEdit/bioedit.html). Phylogenetic maximum
parsimony trees were generated with the TNT program (6).
Jackknife resampling with 1,000 replicates was performed
to evaluate the obtained trees. Phylogenetic analysis of
NS5 fragments placed the Argentinean sequences in the
North American cluster of lineage IA (Figure 2A).
Sequences ArEq001 and ArEq002 showed a 100%
nucleotide (nt) identity with hny1999 and differed by only
1 nt from sequence ArEq003. Phylogenetic analysis of the
C/preM fragments also placed the Argentinean sequences
in lineage IA (Figure 2B). Once again, ArEq001 was iden-
tical to ArEq002 but showed 9 nt differences from
ArEq003. ArEq001 and ArEq002 grouped together
because of 3 point mutations at nt 172, 208, and 245 in our
fragments (corresponding to positions 390, 426, and 463 of
WNV hny1999 strain. Whereas the first 2 mutations are
silent, at position 463 the substitution of G for A results in
a change of valine to isoleucine. Correct placement of
ArEq003 is not clear because of several nucleotide
changes.
Conclusions
Since WNV was first detected in New York in the sum-
mer of 1999, it spread from the Atlantic Coast to the
Pacific Coast in the United States and has affected Canada,
Mexico, and some locations in the Caribbean basin,
Central America, and northern Colombia (7,8). Our results
are further evidence of the expanding geographic distribu-
tion of WNV.
WNV was isolated and detected by molecular tech-
niques in Argentina from 3 horses that had no record of
traveling outside the country during the preceding 4
months and that had not received vaccines against WNV.
San Antonio de Areco may provide ideal conditions for
detecting an enzootic cycle, given that >9,000 horses are
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Figure 2. Phylogenetic trees of West Nile virus (WNV) nucleotide
sequences. Maximum parsimony trees were obtained with TNT
software (6). Values of jackknifing support are indicated at nodes.
GenBank accession nos. ArEq001, ArEq002, and ArEq003:
DQ537383, DQ537385, and DQ811782 (fragments NS5),
DQ537382, DQ537384, and DQ811783 (fragments c/prM); ug37:
M12294; vol99: AF317203, ari04: DQ164201; geo02: DQ164196;
har04: DQ164206; hny1999: AF202541; Kun60: D00246; rum96:
AF260969; Eg51:AF260968. A) NS5 fragment. B) C/preM frag-
ment.raised there. Horses are probably “dead-end” or incidental
hosts in the WNV transmission cycle; 10%–20% of the
infections result in clinical disease, and the mortality rate
in equines varies from 28% to 45% (9). Avian deaths were
not observed in the affected places. Victoria, a potential
site of infection for 1 of the studied equines, is 100 km
southeast of Paraná City, where human flavivirus
encephalitis cases have been diagnosed since February
2006. Cross-neutralization studies with a panel of fla-
viviruses are being conducted to identify the specific etio-
logic agent.
Analysis of the genomic sequences places the 3
Argentinean isolates in WNV lineage IA. Phylogenetic
analysis of the NS5 fragment place them in the North
American cluster, although an additional resolution of this
cluster was not achieved because of high conservation lev-
els and shortage of parsimony informative sites. A clear
resolution of lineage IA clades was not obtained from the
nucleotide sequences of the C/preM fragments.
Nevertheless, a different location for Argentinean
sequences was observed according to geographic origin.
The substitution of valine to isoleucine, detected in
sequences from San Antonio de Areco, was not observed
in any sequence available from GenBank database.
Additional investigation is necessary to establish possible
implications for this change in terms of virulence and tro-
pism of WNV.
WNV could be detected in southern South America
because of the great economic value of the horses, which
are subjected to continual veterinary evaluations. Animals
of less economic value might have become infected and
died without being noticed. The results reported here
emphasize the need for an integrated surveillance system
for WNV in Argentina with greater diagnostic capacity and
the need for development of control strategies.
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